Comparison of Helicobacter pylori positive and negative gastric cancer via multi-omics analysis
mBio, 2023 Helicobacter pylori (H. pylori) has been regarded as a definite carcinogenic bacterium for gastric cancer (GC). This multi-omics research was designed to investigate the genetic, microbial, and metabolic changes of GC patients when they are infected with
Fumei Shang +6 more
doaj +1 more source
H. pylori and platelet counts [PDF]
Hepatology, 2006 Abstract Helicobacter pylori (HP) eradication therapy is a useful treatment for idiopathic thrombocytopenic purpura (ITP). Some investigators have also reported the effects of proton pump inhibitor (PPI) monotherapy on ITP.
Hays L, Arnold, Stephen A, Harrison
openaire +2 more sources
Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia. [PDF]
, 2011 BACKGROUND: The prevalence of Helicobacter pylori including strains with putatively virulent genotypes is high, whereas the H. pylori-associated disease burden is low, in Africa compared to developed countries.
Douglas E. Berg +51 more
core +1 more source
The sodium-dependent D-glucose transport protein of Helicobacter pylori [PDF]
, 2008 Helicobacter pylori is a gram-negative pathogenic microaerophile with a particular tropism for the mucosal surface of the gastric epithelium. Despite its obligatory microaerophilic character, it can metabolize D-glucose and/or D-galactose in both ...
Kim E. Bettaney +21 more
core +1 more source
Helicobacter pylori and Other Gastrointestinal Diseases [PDF]
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2020 Helicobacter pylori (H. pylori) is the most prevalent bacterial pathogen that infects approximately half of the world’s population. It is well known that H. pylori causes chronic gastritis, peptic ulcer, and gastric cancer. H.
Jong Kyu Park
doaj +1 more source
A change of IL-2 and IL-4 production in patients with Helicobactor pylori infection
Mediators of Inflammation, 1995 Helicobactor pylori is the most common cause of gastroduodenal inflammation. However, the exact immune pathogenesis is not fully understood. To look for evidence of the immunological mechanism in H.
X. G. Fan +3 more
doaj +1 more source
Prevalence of Helicobacter pylori infection in dyspeptic patients in Iran
Gastroenterology Insights, 2012 Although Helicobacter pylori (H. pylori) infection has been known to be associated with several upper gastrointestinal disorders such as peptic ulcer and gastric cancer, the relationship between H.
Leila Shokrzadeh +6 more
doaj +1 more source
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]
, 1998 In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Miehlke, Stephan +11 more
core +1 more source
Epigenetic dynamics of Helicobacter pylori-induced COX-2 activation [PDF]
, 2009 Background and Aims: Cyclooxigenase (COX)-2 is over expressed in gastrointestinal neoplasia and Helicobacter pylori (H. pylori) infection is casually linked to gastric cancer. We undertook this study to investigate the mechanism mediating H.
Peluso, Silvia
core +1 more source
Age of the association between Helicobacter pylori and man [PDF]
, 2012 When modern humans left Africa ca. 60,000 years ago (60 kya), they were already infected with Helicobacter pylori, and these bacteria have subsequently diversified in parallel with their human hosts. But how long were humans infected by H.
Linz, B. +62 more
core +1 more source